Hunter Health retweeted
Your legs contain approximately 50% of your skeletal muscle mass and represent your body’s largest metabolic engine.
Beyond strength and locomotion, their mitochondrial function and oxidative capacity are essential for metabolic health, healthspan and longevity.
Healthy legs are much more than strong legs.
#Mitochondria #MetabolicHealth #Longevity #Healthspan
🤖 Made with AI
Hunter Health retweeted
Now it’s OVER FIVE MILLION VIEWS !!
FOUR MILLION VIEWS !!!! Lowcarb goes mainstream in just 5 weeks!! On average my patients lose 10% of their body weight. So grateful to @StevenBartlett for giving me this opportunity to reach so many interested people youtu.be/zc8Nh4TMB1s?si=i73C…
Hunter Health retweeted
Most exercise and aging studies can't answer a basic question: is muscle deterioration from aging itself, or just from decades of moving less? A new Nature Aging study solved this by recruiting older adults who moved as much as people in their twenties.
The researchers from Amsterdam UMC and Maastricht University recruited four distinct groups: young adults in their twenties, older adults whose daily step counts and high-intensity activity matched the young group, older adults who had trained consistently for years (three structured hour-long sessions per week for over a year), and older adults with early physical impairment.
They took muscle biopsies before and after a one-hour cycling session, then measured over 24,000 gene transcripts, 135 metabolites, and 1,383 lipid species.
By matching activity levels between young and older groups, any molecular differences couldn't be blamed on the older adults simply moving less. This isolated aging from inactivity for the first time at this molecular depth.
Key findings:
• The defining molecular signature of muscle aging is an energy crisis. Comparing young adults to activity-matched older adults, 1,106 genes were downregulated with age. These genes build the mitochondrial machinery that produces cellular energy: ATP synthase, cytochrome c oxidase, and NADH dehydrogenase subunits. Mitochondria are the power plants of cells, converting nutrients into ATP, the energy currency cells use to function. When these genes decline, cells lose their ability to generate energy efficiently.
• NAD+ levels declined and triglycerides accumulated inside aging muscle. NAD+ is a molecule required for energy production and cellular repair. Lower NAD+ means less capacity to convert fuel into usable energy. Triglycerides are stored fats, their accumulation inside muscle indicates unburned fuel piling up as the tissue loses its ability to process it.
• More than half the molecular signature of muscle aging was absent in trained older adults. Specifically, 57.1% of age-related gene downregulation and 55.9% of upregulation were missing in the trained group. Their muscle resembled young adults far more than their chronological age would predict.
• The changes training preserved were specifically the energy metabolism ones. Genes like NDUFS1 and COX5A, which were depleted in normally active and impaired older adults, sat at youthful levels in the trained group across all five mitochondrial respiratory complexes. The single most prominent feature of muscle aging turned out to be the single most preventable.
• Being generally active was not enough. Structured training was the difference. The normally active older adults walked as much as young adults, and their energy metabolism genes declined anyway. What preserved the youthful molecular profile was structured, sustained training. Filling a step counter and being genuinely trained are not equivalent at the molecular level.
• Roughly half of muscle aging persisted regardless of training. Changes in genes controlling synaptic transmission (how nerves communicate with muscle) and WNT signaling (a pathway regulating tissue maintenance and stem cell function) appeared in all older adults, trained or not. This unavoidable half is where drugs will have to work.
• The fittest muscle mounted the largest inflammatory response to exercise. All groups activated stress and immune genes after exercise, including IL6, IL1B, and TNF. But the magnitude scaled with fitness. Trained older adults most closely resembled young adults in their response, followed by normally active, with impaired older adults showing the most blunted response. The stress response to exercise appears to be the mechanism of adaptation, not damage to be minimized.
This raises a concern about anti-inflammatory longevity strategies. If the inflammatory stress response is how exercise produces its benefits, chronically suppressing inflammation may blunt the adaptation that exercise depends on. It doesn't mean inflammation is beneficial in general, but the timing and context matter.
A separate discovery: the proteasome appears to regulate NAD+. The proteasome is the cellular machinery that breaks down damaged proteins. When researchers inhibited it, NAD+ levels rose in both muscle and liver cells to a degree comparable to NAD+ precursor supplements. This opens a new route to understanding NAD+ decline that operates through protein turnover rather than just supplying more raw material.
The study draws a clear line between what lifestyle can address and what will require therapeutics. The energy metabolism decline, mitochondrial deterioration, and NAD+ depletion that define muscle aging are largely preventable through structured training. The synaptic and signaling changes that persist in all older adults represent the unavoidable half where drugs will need to work.
The decisions made about structured training in midlife determine which molecular trajectory muscle follows in later decades. Half of muscle aging is optional. The other half isn't. Knowing which changes belong to each category is knowing where behavior ends and biology takes over.
Hunter Health retweeted
VO2 max drops 46% from age 20 to 70, but cardiac output only falls 31%. The gap between those numbers reveals something unexpected about where aging really happens.
For decades, the dominant explanation for declining aerobic capacity with age centered on the cardiovascular system. Your heart beats slower, pumps less blood per beat, and delivers less oxygen to working muscles. This narrative made intuitive sense and aligned with the most visible changes of aging.
But new research quantifies a different story. The limitation isn't just about oxygen delivery. It's increasingly about what happens after the blood arrives at muscle tissue.
VO2 max represents the maximum rate your body can consume oxygen during all-out exercise. It's one of the strongest predictors of longevity and functional independence as we age. Beginning around age 30, it drops roughly 10% per decade in sedentary people.
The Fick equation breaks down what determines VO2 max:
VO2 max = Cardiac Output × Arteriovenous Oxygen Difference
Cardiac output is how much blood your heart pumps per minute. The arteriovenous oxygen difference, or a-vO2 difference, measures how much oxygen your muscles extract from that blood.
This equation splits the aging story into two parts: central factors (heart and lungs delivering oxygen) and peripheral factors (muscles extracting and using oxygen).
Central limitation comes from declining maximal heart rate, which drops about one beat per minute per year after age 20, and reduced stroke volume as the heart stiffens and large arteries lose elasticity.
Peripheral limitation comes from changes in skeletal muscle itself: mitochondrial density and function, capillary networks that deliver blood to muscle fibers, muscle mass, and the enzymes that drive oxidative metabolism.
The new analysis reveals that by late middle age, nearly half of the limitation on VO2 max originates in the periphery, not the cardiovascular system.
In younger adults, approximately 77% of the total limitation is central and 23% peripheral. Your heart and oxygen delivery system are the primary bottleneck.
In older adults, that shifts to roughly 56% central and 44% peripheral. The muscles are catching up to the heart as a source of failure.
The most striking finding: oxygen extraction capacity falls dramatically with age. Skeletal muscle extracts roughly 80% of delivered oxygen at maximal effort in young adults. By ages 75 to 80, that figure drops to approximately 60%.
That's a 20 percentage point decline in the muscle's ability to use the oxygen the cardiovascular system is still delivering.
Four converging biological processes drive this peripheral decline:
1. Sarcopenia preferentially strips away type II muscle fibers, which are rich in mitochondria and oxidative capacity. You lose not just muscle mass, but specifically the muscle tissue most capable of using oxygen.
2. Mitochondrial density and efficiency decline. Mitochondria become fewer in number, smaller in size, and less effective at converting oxygen into usable energy through ATP production.
3. Capillary rarefaction thins the networks of small blood vessels threading through muscle tissue. Fewer capillaries mean longer distances for oxygen to diffuse from blood to muscle cells, creating a bottleneck at the delivery endpoint.
4. Interstitial changes in the space between capillaries and muscle cells further impair oxygen movement. Changes in tissue structure and composition slow the final step of oxygen's journey into working muscle.
None of these is catastrophic alone. Together, they compound into something substantial that previous research underemphasized by focusing primarily on cardiac decline.
Here's what matters for intervention:
• The peripheral factors driving VO2 max decline (mitochondria, capillaries, oxidative enzymes) remain responsive to training well into later decades of life
• Endurance training produces the most reliable capillary growth: 13.3% increase in capillary density and 15% increase in capillary-to-fiber ratio over 8-10 weeks
• High-intensity interval training (HIIT) delivers comparable mitochondrial gains to endurance training but requires substantially less total time, estimated at 1.7x more time-efficient
• Sprint interval training (SIT) generates the fastest mitochondrial signal per minute of any modality, producing 3-5x greater VO2 max improvement per hour of exercise, though it doesn't significantly increase capillary density
• Meaningful adaptation begins within two weeks. Roughly 13.7% of total mitochondrial gains from an endurance block occur in the first 14 days
• The biological machinery that aging erodes is the same machinery that training can partially rebuild, even in the seventh and eighth decades of life
The practical implication: maintaining VO2 max with age isn't just about keeping your cardiovascular system fit. You need training that specifically targets peripheral adaptations, the cellular machinery inside muscle tissue that extracts and uses oxygen.
That means prioritizing exercise intensity that creates metabolic stress sufficient to trigger mitochondrial remodeling and capillary growth. Moderate-intensity steady-state exercise improves cardiovascular fitness but generates weaker peripheral adaptation signals than high-intensity work.
The framework also explains why training becomes more important, not less, as you age. When you're 25 and 77% of your VO2 max limitation is central, peripheral decline happens quietly in the background. By 65, when peripheral factors account for nearly half the limitation, those quiet changes have accumulated into the primary driver of functional decline.
The decisions made in the fourth and fifth decades of life shape the physiological ceiling of the seventh and eighth. Aerobic aging is a slow, cumulative process affecting multiple systems simultaneously. So is the adaptive response to training.
The most important variable isn't the perfect training modality. It's consistency across the decades during which the oxygen cascade is quietly remodeling in one direction or the other.
Hunter Health retweeted
Brand new study just dropped (published Oct 29, 2026 in Frontiers in Pharmacology).
A massive new analysis from two of the world’s largest biomedical databases just linked statin use to roughly double the risk of dementia.
Researchers looked at the All of Us Research Program (83,355 adults, including over 31,000 statin users, followed through 2023) and the UK Biobank (173,282 adults, including nearly 44,000 statin users). After balancing groups for age, BMI, APOE status, comorbidities, and other factors using inverse probability of treatment weighting, statin users showed adjusted hazard ratios of 2.22 (All of Us) and 2.54 (UK Biobank) for incident dementia.
The association held across Alzheimer’s disease, vascular dementia, and other subtypes. High-intensity statins carried an additional ~14% higher risk compared with moderate-to-low intensity therapy. Incidence rates were higher in the discovery cohort (64.9 vs 30.7 per 10,000 person-years) than in the replication cohort, but the relative increase was consistent.
In an exploratory mediation analysis, a modest portion (8.2%) of the association appeared to run through lower levels of coenzyme Q7—a protein involved in CoQ10 biosynthesis. Lower COQ7 was itself linked to higher dementia odds. The pathway through LDL-C was not statistically significant. The authors note this is hypothesis-generating and that direct CoQ10 was not measured.
This is observational data, not a randomized trial, so it cannot prove causation. Residual confounding (including why people were prescribed statins) remains possible, and the literature on statins and cognition has been mixed. Still, the scale, the replication across two independent cohorts, the intensity-dependent pattern, and the COQ7 signal make it hard to ignore.
This is the kind of result that makes people who have been skeptical of long-term statin use for primary prevention sit up and take notice—especially given the CoQ10 connection many clinicians have quietly acknowledged for years.
The full paper is open access: frontiersin.org/journals/pha…
Hunter Health retweeted
Normalmente, todos consideram brotos de brócolis saudáveis, até você ler as pesquisas sobre NRF2 que saem da Johns Hopkins, daí o negocio vai pra outro nivel!
O sulforafano é o ativador natural mais poderoso da via mestra de desintoxicação do corpo já descoberto.
Então, deixa de parecer legume e começa a parecer farmacologia.
O NRF2 é o interruptor mestre que controla mais de 200 genes protetores simultaneamente.
Quando ativado, ele coloca em funcionamento toda a rede de defesa antioxidante do seu corpo de uma vez.
Não um gene. Duzentos.
O sulforafano ativa o NRF2 com mais potência do que qualquer outro composto natural já testado.
É isso. Uma molécula. Duzentos genes.
A relação entrada-saída mais eficiente da ciência nutricional.
• Induz as enzimas de desintoxicação de fase 2 que neutralizam carcinógenos antes que eles danifiquem o DNA.
Estudado de forma aprofundada na Johns Hopkins há mais de 25 anos.
• Reduz o tamanho e o número de tumores em modelos animais de câncer.
Ensaios clínicos em humanos estão em andamento ativamente.
• Atravessa a barreira hematoencefálica. Neuroprotetor contra marcadores de Parkinson em pesquisas preliminares.
• Melhora os marcadores do transtorno do espectro autista em um ensaio controlado randomizado.
Um dos poucos compostos que demonstraram isso.
• Reduz os marcadores inflamatórios em todos os tecidos testados, incluindo intestino, fígado e cérebro.
• Fortalece a capacidade do seu corpo de processar e eliminar toxinas ambientais, metais pesados e partículas de poluição atmosférica.
Os brotos contêm de 10 a 100 vezes mais precursor de sulforafano do que o brócolis do supermercado.
E a maioria dos suplementos de sulforafano não tem mirosinase, a enzima necessária para converter o precursor no composto ativo.
Sem mirosinase, a cápsula é biologicamente inerte.
Cultive o brócolis em casa.
Pode ser em vasos.
Compre sementes para germinar.
De água de 3 a 5 dias desde plantar a semente o broto comestível.
É barato.
Coma de 30 a 60 g por dia.
Ou compre um suplemento que contenha explicitamente mirosinase (verifique o rótulo, a maioria não tem).
O composto quimioprotetor mais poderoso da natureza cresce em um vaso na sua bancada de cozinha por menos do que o preço de um café.… x.com/daacervo/statu
Hunter Health retweeted
Our cells emit faint biological light, and understanding that light could help us recognize when life may begin to move away from a healthy state.
Today on TSEE, @niroshajmurugan shares insights from her cancer research into how biological light arises from cellular chemistry and how its changing patterns may help detect cancer.
By bringing quantum science & technology into the study of living systems, ultra-sensitive detectors are helping us explore whether biological light could support non-invasive health monitoring. The ambition is to recognize meaningful changes earlier and develop applications that help us protect and promote health.
tseenergy.substack.com/p/can…
Hunter Health retweeted
Complete Glucose Oxidation ⚡
An extraordinary masterpiece of cellular machinery. Essential for cellular survival, health and athletic performance, yet potentially devastating to our health when it malfunctions.
The mitochondrial pyruvate carrier (MPC) and mitochondrial lactate oxidation complex (mLOC) will be highly studied in the next decade as they are central to understand glucose metabolism and cellular dysregulations in diseases like diabetes, cancer or Alzheimer’s.
*For endocrinologists working with T2D patients please understand these mechanisms. They are key to understand and manage diabetes. This can be done today already.
Hunter Health retweeted
🚨 It’s finally out!
The video that explains clearly what we believe is happening when infrared light hits the mitochondria.
It’s worth the whole watch!
How Infrared Light Actually Affects Your Mitochondria - Hypothesis
youtu.be/ID5k4G3ogqM
Hunter Health retweeted
If you ever encounter a fanatic mitochondriac trying to convince you that mitochondria are the powerhouse of the cell and the most fascinating element of your body—don’t be fooled.
Mitochondria are way more than powerhouses…
Diffuse their delusion: open.substack.com/pub/tseene…
Hunter Health retweeted
Can Fatty acids and Ketone Bodies Fuel Cancer?
Many people claim that some cancers, especially prostate cancer, can use fatty acids and ketone bodies for energy (ATP production) and that ketogenic metabolic therapy will not work for cancers that can use fatty acids for energy. Research shows that all major cancers depend on the oxygen independent fermentation of the sugar glucose and the amino acid glutamine for energy. Multiple defects in the structure and function of cancer cell mitochondria are responsible for the dependency on fermentation for energy (doi.org/10.1007/s10863-025-1…). These mitochondrial defects reduce energy through oxygen-driven respiration (OxPhos) even in the presence of oxygen thus creating the well-documented addiction of cancer cells to glucose and glutamine for growth. Cancer cells need glucose and glutamine not only to produce energy but also for the synthesis of RNA & DNA.
Fatty acids and ketone bodies require oxidation in functional mitochondria for energy production and cannot be fermented or used for RNA or DNA synthesis as can glucose and glutamine. Consequently, fatty acids and ketone bodies cannot replace glucose and glutamine as fuels for ATP synthesis in cancer (doi.org/10.1016/j.isci.2020.…). Fatty acids often accumulate in the cancer cell cytoplasm as lipid droplets because they cannot be effectively oxidized for energy. Please see the beautiful pictures of lipid droplet accumulation in different cancers (rdcu.be/dIhNT). It is important to know, however, that fatty acids can enhance mitochondrial uncoupling. Uncoupling is like pumping air into a tire that contains holes. Uncoupling increases oxygen consumption and the fermentation of glucose and glutamine thus making it appear as if cancer cells can use fatty acids for energy. No evidence has been presented showing that fatty acids or ketone bodies can drive dysregulated tumor cell growth in the absence of glucose and glutamine.
Hunter Health retweeted
Your brain switches between glucose, lactate, ketones, and fatty acids throughout the day to match energy demand. In Alzheimer's disease, this fuel flexibility is progressively lost. A Journal of Neurochemistry review reveals why the brain gets metabolically stuck.
Alzheimer's disease has long been characterized by reduced glucose metabolism visible on brain scans. The standard interpretation was that neurons couldn't access enough fuel. But a new framework from researchers at the University of Kentucky proposes something different: the brain isn't starving for energy. It's locked into a rigid metabolic program that can't adapt to changing needs.
Metabolic flexibility describes the ability of cells to sense, access, and switch between different fuel sources based on availability and demand. In a healthy brain, neurons primarily use glucose.
But they can also run on lactate produced by support cells called astrocytes.
During fasting or ketogenic diets, both neurons and glia can use ketones.
Fatty acids provide another backup fuel source.
This fuel switching happens constantly. After a meal, the brain uses glucose. During sleep, it may shift toward lactate and ketones. Under metabolic stress, cells activate alternative pathways to maintain energy production. The system stays flexible, matching fuel use to functional requirements.
In Alzheimer's disease, this adaptability breaks down.
The review argues that AD is fundamentally a disorder of metabolic inflexibility where cellular metabolism gets actively reprogrammed to support inflammatory and disease-associated processes at the cost of neuronal function.
Alzheimer's disease doesn't progress in a straight line of declining metabolism. It unfolds in two distinct phases that seem contradictory.
In the early stages, often years or decades before symptoms appear, the brain actually burns more glucose than normal. This hypermetabolism comes from immune cells ramping up their energy consumption to fight inflammation. Think of it as the brain running hot, immune cells working overtime.
Later, in the stages when cognitive decline becomes apparent, the pattern flips. The whole brain shifts into hypometabolism, burning less glucose than it should. This is the energy collapse, where neurons can't get enough fuel to maintain normal function. By this point, the metabolic machinery that would allow cells to adapt has broken down.
The shift from early hypermetabolism to late-stage collapse follows a biphasic trajectory:
• Early stage: Immune cells and support cells burn excessive glucose to fuel inflammation
• Late stage: Brain-wide energy shortage as neurons lose access to fuel
The brain's immune cells, called microglia, drive this metabolic shift. When they detect damage, they switch to a faster way of burning glucose that prioritizes speed over efficiency. This helps them respond to threats quickly. But once locked into this mode, they consume glucose at rates that starve nearby neurons of fuel.
Support cells called astrocytes normally convert glucose into lactate and deliver it to neurons as fuel. In Alzheimer's disease, these cells stop making lactate and start hoarding glucose for themselves instead. The fuel pipeline to neurons shuts down.
Both cell types lose their flexibility. They get stuck burning fuel in ways that support their own inflammatory responses but cut off the energy supply that neurons need to function.
This metabolic rigidity creates a vicious cycle. When cells can't switch fuels flexibly, they get stressed. That stress increases production of amyloid-β plaques and tau tangles, the hallmark proteins of Alzheimer's disease. These proteins trigger more inflammation, which locks cells even deeper into their rigid metabolic programs.
The damage spreads beyond individual cells. Neurons become overactive when they can't meet energy demands, throwing off the brain's excitation-inhibition balance. Network connectivity breaks down. Sleep fragments. Cognitive function declines as the whole system fails to coordinate.
System-level consequences include:
These cellular-level changes show up as system-wide brain dysfunction:
• Neurons fire erratically when starved of energy, disrupting communication patterns
• The default mode network, critical for memory and self-referential thinking, loses connectivity
• Sleep architecture deteriorates, reducing the brain's ability to clear waste during rest
• Memory, attention, and executive function decline as metabolic failure spreads across brain regions
Here's what makes this framework different from viewing Alzheimer's as simple energy failure: the metabolic programs are initially adaptive. Microglia activate glycolysis because it helps them respond to damage. Astrocytes shift fuel use to support their own functions under stress. These are protective responses.
But they become chronically maladaptive. What works as a short-term stress response traps the brain in a metabolic state that can't support normal neuronal function. The longer these programs run, the more rigid they become, and the harder it is for cells to switch back to flexible fuel use.
The critical insight from the review: metabolic inflexibility may be reversible.
Unlike permanent structural damage, metabolic programs can potentially be reprogrammed.
The authors propose that restoring metabolic flexibility could mitigate amyloid and tau pathology, reduce neuronal loss, and improve functional outcomes.
Evidence supporting reversibility comes from preclinical studies testing metabolic interventions.
Ketogenic diets, which force the brain to use ketones instead of glucose, have shown some cognitive benefits in animal models and small human trials. Compounds that enhance mitochondrial function or shift cells away from pure glycolysis are being tested.
Other approaches target specific aspects of metabolic inflexibility.
Drugs that improve insulin signaling in the brain could help cells take up and use glucose more effectively.
Interventions that reduce microglial inflammation might allow these cells to return to more balanced metabolic programs. Enhancing the astrocyte-neuron lactate shuttle could restore an important fuel pathway.
The review synthesizes human neuroimaging data showing regional patterns of hypometabolism that correlate with cognitive decline, cerebrospinal fluid studies demonstrating altered metabolite profiles, and animal research revealing the cellular mechanisms behind these changes.
Clinical trials are actively testing metabolic interventions.
Some focus on dietary approaches like ketogenic diets or medium-chain triglycerides that boost ketone availability.
Others test drugs that improve glucose metabolism or mitochondrial function.
Results so far have been mixed, but the framework suggests timing matters. Early intervention, before metabolic programs become too rigid, may be critical.
The view of Alzheimer's disease as a disorder of metabolic inflexibility reframes how we think about disease progression. It's not just about plaques and tangles accumulating. It's about the brain's support systems getting stuck in metabolic states that prioritize inflammation over neuronal support, speed over efficiency, and short-term survival over long-term function.
Those choices, made at the cellular level, compound over time. They create an environment where neurons can't get the fuel they need in the forms they can use. Network function deteriorates. Cognitive abilities decline. The brain collapses energetically not because fuel is absent, but because the metabolic machinery to access and use it flexibly has been dismantled.
Restoring that flexibility means more than just providing alternative fuels. It means helping cells regain the ability to switch between fuels based on need, rebalancing the metabolic priorities of glia to support rather than compete with neurons, and breaking the feed-forward cycles that lock the brain into rigid metabolic programs.
Whether this approach translates into effective therapies remains to be determined. But redefining Alzheimer's disease as metabolic inflexibility rather than simple metabolic failure opens new intervention points at stages of disease where structural damage may still be limited and metabolic programs potentially reversible.
Hunter Health retweeted
🦴 ¿Cuánto ejercicio necesita el hueso?
🏃 Caminar rápido o trotar y combinar aeróbico + fuerza parecen aumentar la densidad mineral ósea en adultos ≥40 años.
⏱️ ~2–3 h/semana podrían ser suficientes.
bmj.com/content/394/bmj-2026…
Hunter Health retweeted
Low carb diets and renal function We showed for our patients with T2Diabetes kidney function improved on a low carb diet pubmed.ncbi.nlm.nih.gov/3446… @weimbslab
Hunter Health retweeted
Eggs are insane. so much more than just protein and vitamins. you could spend a lifetime studying its unique proteins and lipids and their therapeutic effects.
Hunter Health retweeted
Confirmed by @bmj_latest our 2023 low carb paper is the most popular paper ever published by @BMJNutrition I’m so proud of this achievement It shows the huge worldwide interest in dietary approaches to T2 Diabetes 🤩🥳 journals.bmj.com/research-im…
Hunter Health retweeted
This review describes how sarcopenia impacts muscle function and its capacity to regenerate after injury, with a focus on metabolic dysregulation, discussing the importance of systemic communication on muscle ageing and health and highlighting the positive impact of exercise on muscle during ageing.
Hunter Health retweeted
We once considered a Cholesterol Level of 350 perfectly normal & healthy.
Then it was lowered to 300.
Then to 240.
Then to 190.
Now doctors want your levels as low as statins can force them — no matter what.
Every single time the “safe” number drops, millions more healthy people are suddenly labeled as needing medication.
This isn’t medicine. It’s a business model. Statins generate over $22 billion every year.
The truth is, the cholesterol hypothesis has been heavily questioned for decades. The famous Framingham Heart Study that helped launch the fear actually showed that for every 1 mg/dL drop in cholesterol per year, there was an 11% increase in both coronary and total mortality.
Large reviews of elderly populations (over 68,000 people) found that those with the highest LDL cholesterol lived the longest.
Yet studies on statins show they extend average life expectancy by only about 3.2 days.
Lowering cholesterol harms the body because cholesterol is essential. It forms every cell membrane, protects your brain, produces hormones, and helps repair arteries.
Statins come with a long list of serious side effects, including:
- Liver inflammation & damage
- New-onset Type 2 diabetes
- Heart failure & cardiomyopathy
- Vertigo, dizziness, cognitive impairment
- ALS, aphasia, dementia & Alzheimer’s
- Cancer
- Pancreatitis
- Parkinson’s
- Muscle tearing & rhabdomyolysis
- Fatigue, weakness & neuropathy
- Hormone deficiency
- MS, epilepsy & clinical depression
Real culprits behind heart disease: chronic inflammation, seed oils, excess sugar, and processed carbohydrates — not cholesterol itself.
Your body makes most of its cholesterol for good reason. Forcing it dangerously low can create more problems than it solves.
Share this with anyone being pushed toward statins.
Higher LDL in the elderly is linked to longer life in multiple studies.
The constant lowering of “normal” cholesterol numbers benefits drug sales far more than patients.
Food is medicine. Real healing starts with what you eat.
Hunter Health retweeted
Sprint-interval exercise lasts less than 5 minutes but triggers more profound metabolic changes than 90 minutes of moderate cycling. A new study reveals why intensity, not duration, reshapes how your organs communicate.
Researchers tracked nearly 3,000 proteins in blood before, immediately after, and 3 hours following two types of exercise in young, healthy males. Sprint-interval exercise consisted of six 30-second all-out cycling bursts with 4-minute rests between sets. Moderate-intensity exercise was 90 minutes of continuous cycling.
The difference was striking. Sprint intervals altered 714 proteins immediately after exercise, more than 98% of which increased. Moderate-intensity exercise changed only 7 proteins at the same timepoint. The number increased to 19 after 3 hours, but remained dramatically lower than the sprint response.
Think of your bloodstream as a communication highway. After intense exercise, it floods with signals that travel to different organs. The study identified proteins originating from muscle, fat tissue, liver, brain, immune cells, pancreas, and other organs.
Skeletal muscle proved particularly sensitive to intensity. The researchers isolated human muscle cells and electrically stimulated them to mimic different exercise types. Simulated sprint exercise released 212 proteins into surrounding fluid. Simulated moderate exercise released only 9.
But muscle wasn't working alone. Sprint exercise increased proteins from the pituitary gland that regulate stress responses, factors from the brain involved in blood vessel relaxation, and immune proteins that modulate inflammation. The pattern suggested coordinated signaling across multiple organ systems.
The study also examined exercise metabolites, small molecules involved in energy production and cellular signaling. Sprint exercise immediately increased lactate, pyruvate, malate, and the obesity-suppressing compound N-lactoyl-phenylalanine (Lac-Phe). Moderate exercise showed a delayed response, with fatty acids rising primarily at the 3-hour mark.
To understand where these signals end up, researchers exposed human fat cells to blood plasma collected after each exercise type. Plasma from sprint exercise triggered extensive changes to fat cell gene activity, affecting 1,128 genes. Plasma from moderate exercise changed only 25 genes.
The remodeled fat cells showed activation of pathways controlling hormone responses, nutrient sensing, and fat breakdown. Several immune signaling receptors increased, suggesting exercise plasma primes fat tissue to respond to inflammatory signals differently.
The findings held up in real tissue. When researchers biopsied abdominal fat before and 3 hours after a maximal treadmill test, 418 genes overlapped with those changed by sprint plasma in isolated cells. This confirms circulating factors from intense exercise genuinely alter fat tissue biology.
Not all changes disappeared with training. After 8 weeks of regular exercise, the same intensity-dependent patterns persisted when participants repeated the acute tests. Growth hormone, von Willebrand factor, and POMC still increased more after sprints than moderate sessions.
The clinical relevance became clear when researchers cross-referenced exercise-responsive proteins with a database tracking 53,026 people for disease outcomes. They identified 143 proteins increased by exercise that associated with lower disease risk.
Of the 33 proteins specifically protective against type 2 diabetes, metabolic disorders, and obesity, 32 were elevated by sprint-interval exercise. Only 3 were elevated by moderate-intensity exercise. Proteins like ADGRG2, FGFBP1, and MXRA8 consistently showed strong protection across multiple metabolic conditions.
This isn't an argument against moderate exercise. The sustained energy demands of longer duration activity clearly stimulate different adaptive pathways, particularly in the liver. Proteins like IGFBP1 and follistatin increased exclusively after moderate exercise, likely reflecting sustained shifts in insulin and glucagon signaling.
The study reveals exercise intensity as a distinct variable that determines which protective signals reach your tissues, which organs respond, and potentially which disease risks decrease. The time-efficient nature of high-intensity exercise appears to work through fundamentally different signaling mechanisms than longer moderate sessions.
Key findings:
• Sprint-interval exercise altered 714 blood proteins immediately post-exercise vs. 7 for moderate-intensity exercise
• 25% of all detectable proteins changed after sprint exercise, with >98% increasing rather than decreasing
• Muscle cells released 212 proteins after simulated sprint exercise vs. 9 after simulated moderate exercise
• Sprint exercise plasma changed 1,128 genes in human fat cells vs. 25 genes for moderate exercise plasma
• Of 33 proteins protective against diabetes and obesity, 32 increased after sprint exercise vs. 3 after moderate exercise
• Intensity-dependent responses persisted after 8 weeks of training, suggesting they reflect relative intensity rather than training status
• Exercise metabolites showed distinct temporal patterns: lactate and Lac-Phe peaked immediately after sprints, while fatty acids increased later
• Moderate exercise uniquely increased liver-derived proteins (IGFBP1, follistatin) at the 3-hour timepoint
The mechanistic picture is incomplete. The study couldn't definitively prove which organs secrete which proteins, relying instead on tissue-specific gene expression databases and cell culture models. Blood volume shifts during exercise also complicate interpretation, though the findings held after correcting for plasma concentration changes.
The research focused on young, healthy, predominantly male participants. Whether the same intensity-dependent patterns occur in women, older adults, or people with existing metabolic disease remains unknown. The protective associations came from observational data that can't prove causation.
Still, the study offers a framework for understanding why brief, intense exercise produces adaptations comparable to or exceeding longer moderate sessions. The answer appears to lie in differential organ crosstalk triggered by metabolic stress signals that moderate exercise simply doesn't generate.

































